Montefiore Einstein Cancer Center
In 2020, the Montefiore Einstein Cancer Center not only provided outstanding clinical care to our patients, it also offered the social and emotional support needed during the COVID-19 pandemic. Despite the challenges presented by an unprecedented year, we made remarkable achievements in clinical, programmatic and research settings.
DATA & STATISTICS
2020 by the numbers
Dollars in research funding from the NCI, NIH and other sources
Therapeutic clinical trial accruals
Inpatient, outpatient and community-based locations
Taking a stand against racial inequality and injustice
In a year marked by social and political upheaval, Montefiore Einstein Cancer Center stood with healthcare colleagues across the country and around the world in the White Coats for Black Lives movement.
Top four enrolling site for NCI-funded anal cancer prevention study
The Anal Cancer HSIL Outcomes Research (ANCHOR) study seeks to prove that anal cancer can be prevented through routine screening and detection of precancerous cells. To date, Montefiore Einstein Cancer Center has enrolled 304 patients.
Haiying Cheng, MD, PhD receives $792,000 Research Scholar Grant
Awarded by the American Cancer Society, the grant supports thoracic medical oncologist Dr. Cheng in her metastatic lung cancer studies, particularly how the RICTOR gene may offer a new target for combatting lung cancer’s spread.
Britta Will, PhD, wins 2020 Pershing Square Sohn Prize for Young Investigators in Cancer Research
Dr. Will, an Assistant Professor of Medicine and Cell Biology, was one of only seven NYC-based scientists to receive the award, which provides $600,000 over three years for innovative basic science cancer research.
Ana Acuña Villaorduña, MD, earns 2020 ASCO Young Investigator Award
Dr. Acuña Villaorduña, a medical oncologist, won the American Society of Clinical Oncology award with her proposal, “A Phase II study to evaluate the efficacy and safety of sirolimus in subjects with metastatic, mismatch-repair deficient solid tumors after immunotherapy.”
$5.1 million NCI grant awarded to Montefiore Einstein Cancer Center researchers
The five-year grant from the National Cancer Institute will help further evaluate novel tests developed by researchers at Montefiore Einstein Cancer Center, which help predict whether primary breast tumors are likely to spread.
Improving care and outcomes through research
Over the course of 2020, we published on a wide variety of topics, including CAR T-cell therapy, chemotherapy benefits in breast cancer and the impact of COVID-19 on cancer patients.
Axicabtagene Ciloleucel CD19 CAR-T Cell Therapy Results in High Rates of Systemic and Neurologic Remissions in Ten Patients...
Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis...
Association of Race and Ethnicity with Comorbidities and Survival Among Patients with COVID-19 at an Urban Medical Center in New York
Advancing care through clinical trials
In 2020, Montefiore Einstein Cancer Center had 251 therapeutic clinical trial accruals, 169 of which were active protocols, including interventions addressing a broad range of solid tumors and hematologic malignancies. Below is a list of featured active protocols from last year.
FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy Versus Standard Therapy for Advanced Non-small Cell Lung Cancer: A Phase I/II Randomized Trial
Nitin Ohri, MD
An Open Label Dose Escalation Trial of CA-4948 in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome: IRAK4 Inhibitor in MDS/AML
Amit Verma, MD
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma (CARTITUDE-2)
Phase II Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects with Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy
Sanjay Goel, MD
Updates and additions to our world-renowned faculty
Edward Chu, MD, MMS
Director, Albert Einstein Cancer Center
Vice President, Cancer Medicine, Montefiore Medicine
Carol and Roger Einiger Professorship of Cancer Medicine
Professor, Molecular Pharmacology
Abier A. Abdelnaby, MD
Director, Colorectal Surgery Service
Associate Professor, Surgery
Othón Wiltz, MD
Assistant Professor, Surgery
Amanda C. Rivera, MD
Attending Physician, Radiation Oncology
Assistant Professor, Radiation Oncology
Anjuli M. Gupta, MD
Director, High-Risk Breast Cancer Program
Breast Surgeon, Surgery
Assistant Professor, Surgery
Ana R. Acuna Villaorduna, MD
Attending Physician, Medical Oncology
Assistant Professor, Medicine (Oncology)
Lili Zhang, MD, ScM
Director, Cardio-Oncology Program
Attending Physician, Medicine (Cardiology)
Assistant Professor, Medicine (Cardiology)
At Montefiore Einstein Cancer Center, we know providing patients with the best possible care includes teamwork and trust. We work closely with our valued referring physicians to ensure open communication and reliable expertise.